Miyarisan Pharmaceutical Co., Ltd. Product Intelligence

Miyarisan Pharmaceutical Co., Ltd. is a Manufacturer, Distributor, Research and Development in the Pharmaceutical Manufacturing industry. It develops, sources, and produces medicinal and therapeutic products — covering prescription drugs, OTC formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. The company serves pharmaceutical brands, healthcare providers, hospital networks, and regulated distribution channels.

Miyarisan Pharmaceutical Co., Ltd. was founded in 1947. That history reflects deeper regulatory expertise, more validated manufacturing processes, and stronger relationships with approved API suppliers and healthcare buyers.

Miyarisan Pharmaceutical Co., Ltd. is headquartered in Japan. Location directly affects regulatory jurisdiction — US-based manufacturers operate under FDA oversight, while companies in other regions follow EMA, WHO-GMP, or local health authority frameworks.

Miyarisan Pharmaceutical Co., Ltd. operates as a Manufacturer, Distributor, Research and Development. Manufacturers develop and produce pharmaceutical formulations; CDMOs provide contract development and manufacturing for third-party brands; API suppliers deliver raw active ingredients to formulators. Miyarisan Pharmaceutical Co., Ltd. may operate across more than one of these roles.

Visit nexusplatform.ai/company/details/miyarisan.com for the full profile — company type, key contacts, product range, therapeutic areas, and certifications, all in one place.

Miyarisan Pharmaceutical Co., Ltd. is led by Koji Uno, President & CEO. Leadership in pharmaceutical manufacturing typically comes from medicinal chemistry, regulatory affairs, clinical development, or operations — backgrounds that directly shape product safety, compliance, and pipeline strategy.